| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.08 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.067 | 0.08 |